UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$4.47B |
| 2 |
Vanguard Russell 1000 Growth ETF
VONG
|
+$2.93B |
| 3 |
Vanguard Russell 1000 Value ETF
VONV
|
+$2.75B |
| 4 |
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
|
+$2.69B |
| 5 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$2.33B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$1.44B |
| 2 |
Micron Technology
MU
|
+$919M |
| 3 |
CYBR
CyberArk
CYBR
|
+$851M |
| 4 |
Honeywell
HON
|
+$606M |
| 5 |
Merck
MRK
|
+$605M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 39.16% |
| 2 | Technology | 16.96% |
| 3 | Financials | 8.4% |
| 4 | Industrials | 7.09% |
| 5 | Healthcare | 6.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
JAGU
7351
Jaguar Uranium Corp
JAGU
$24M
| $45K | ﹤0.01% |
+16,359
| New | +$38.2K |
2026 Q1
0 quarters
|
|
7352
Fidelity International Multifactor ETF
FDEV
$274M
| $44.9K | ﹤0.01% |
+1,259
| New | +$45.5K |
2026 Q1
0 quarters
|
|
7353
PUT
KE Holdings
BEKE
$18.1B
| $44.9K | ﹤0.01% |
3,000
-2,546,000
| -100% | -$43.7M |
2024 Q3
6 quarters
|
|
|
TSYX
7354
TSPY Lift ETF
TSYX
$16.4M
| $44.8K | ﹤0.01% |
+2,122
| New | +$48.8K |
2026 Q1
0 quarters
|
|
|
DHY
7355
UBS Asset Management High Yield Credit Fund
DHY
$222M
| $44.8K | ﹤0.01% |
2,356
| – | – |
2014 Q4
45 quarters
|
|
7356
SP Funds S&P Global Technology ETF
SPTE
$267M
| $44.7K | ﹤0.01% |
+1,290
| New | +$46.9K |
2026 Q1
0 quarters
|
|
|
EURKU
7357
Eureka Acquisition Corp Unit
EURKU
$61.1M
| $44.7K | ﹤0.01% |
4,270
| – | – |
2024 Q3
6 quarters
|
|
|
WEA
7358
Western Asset Premier Bond Fund
WEA
$117M
| $44.7K | ﹤0.01% |
4,225
-216
| -5% | -$2.37K |
2014 Q4
45 quarters
|
|
|
GRO
7359
Brazil Potash Corp
GRO
$133M
| $44.7K | ﹤0.01% |
13,789
+3,848
| +39% | +$10.9K |
2025 Q2
3 quarters
|
|
7360
Altisource Portfolio Solutions
ASPS
$72.7M
| $44.6K | ﹤0.01% |
6,995
+5,941
| +564% | +$36.9K |
2024 Q1
8 quarters
|
|
7361
Inspire 100 ETF
BIBL
$501M
| $44.6K | ﹤0.01% |
+945
| New | +$45.6K |
2026 Q1
0 quarters
|
|
|
TOYO
7362
TOYO Co
TOYO
$187M
| $44.5K | ﹤0.01% |
+6,077
| New | +$46.8K |
2026 Q1
0 quarters
|
|
7363
Armata Pharmaceuticals
ARMP
$131M
| $44.5K | ﹤0.01% |
4,349
+3,328
| +326% | +$28K |
2018 Q2
31 quarters
|
|
7364
INNOVATE Corp
VATE
$102M
| $44.5K | ﹤0.01% |
7,830
+58
| +0.7% | +$294 |
2014 Q4
45 quarters
|
|
|
XOVR
7365
EntrepreneurShares Series Trust ERShares Private-Public Crossover ETF
XOVR
$1.53B
| $44.3K | ﹤0.01% |
2,620
+2,572
| +5,358% | +$46.8K |
2025 Q3
2 quarters
|
|
7366
Theriva Biologics
TOVX
$10.3M
| $44.2K | ﹤0.01% |
225,624
+34,214
| +18% | +$6.74K |
2023 Q4
9 quarters
|
|
|
ESIM
7367
Eventide International ETF
ESIM
$26M
| $44.2K | ﹤0.01% |
+1,751
| New | +$46K |
2026 Q1
0 quarters
|
|
7368
CB Financial Services
CBFV
$187M
| $44.2K | ﹤0.01% |
1,292
-889
| -41% | -$31.1K |
2018 Q2
31 quarters
|
|
|
NBIL
7369
GraniteShares 2x Long NBIS Daily ETF
NBIL
$209M
| $44K | ﹤0.01% |
+4,248
| New | +$48K |
2026 Q1
0 quarters
|
|
7370
Natural Health Trends
NHTC
$8.58M
| $43.9K | ﹤0.01% |
15,730
-11,974
| -43% | -$40K |
2024 Q3
6 quarters
|
|
7371
FitLife Brands
FTLF
$86.6M
| $43.9K | ﹤0.01% |
3,089
+191
| +7% | +$2.86K |
2024 Q4
5 quarters
|
|
7372
First Trust Indxx Innovative Transaction & Process ETF
LEGR
$127M
| $43.8K | ﹤0.01% |
+758
| New | +$45.7K |
2026 Q1
0 quarters
|
|
7373
USCB Financial Holdings
USCB
$417M
| $43.7K | ﹤0.01% |
2,359
-5,534
| -70% | -$105K |
2022 Q4
13 quarters
|
|
|
OGI
7374
Organigram Holdings
OGI
$137M
| $43.7K | ﹤0.01% |
32,615
+25,873
| +384% | +$38.4K |
2019 Q2
27 quarters
|
|
7375
Morgan Dempsey Large Cap Value ETF
MDLV
$47.5M
| $43.5K | ﹤0.01% |
1,443
+788
| +120% | +$23.7K |
2025 Q4
1 quarter
|
|
Similar funds
UBS Group's Q1 2026 Portfolio in Review
As of Q1 2026, UBS Group held 11,786 positions worth $666B, up 8% from $617B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group deployed $74.2B of net new capital in Q1 2026, opening 1,344 new positions and adding to 4,798 existing holdings. Its largest new stake was Sunbelt Rentals Holdings: 1,909,539 shares worth $124M.
By sector, the portfolio is most concentrated in Miscellaneous at 39% of assets, up from 38% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was UBS Group, an estimated $1.44B trimmed.
- UBS Group's largest Q1 2026 buy was Sunbelt Rentals Holdings: 1,909,539 shares worth $124M.
- UBS Group added most to iShares Core MSCI EAFE ETF in Q1 2026, an estimated $4.47B increase.
- UBS Group's biggest Q1 2026 reduction was UBS Group, cutting an estimated $1.44B.
- UBS Group fully exited CyberArk in Q1 2026, selling an estimated $851M.
- UBS Group's ten largest holdings make up 13% of its $666B portfolio in Q1 2026.
- UBS Group opened 1,344 new positions and closed 1,383 in Q1 2026.
- UBS Group's portfolio value rose 8% quarter-over-quarter to $666B.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.